Trial Search Results
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.
Stanford is currently accepting patients for this trial.
University of Wisconsin, Madison
Collaborator: University of Texas
- Other: MRI
- know or suspected iron overload
- contraindication to magnetic resonance imaging
Ages Eligible for Study
10 Years - 89 Years
Genders Eligible for Study